BioCatalyst

ACE1831, Lymphodepleting chemotherapy — catalyst calendar

1 verified catalyst event(s) referencing ACE1831, Lymphodepleting chemotherapy, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-20
in 4mo
ESTIMATED
 READOUT
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With Ig
Phase 1/2 · IgG4 Related Disease
 Acepodia Biotech, Inc. ACE1831, Lymphodepleting chemotherapy ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.